Literature DB >> 9893345

Structure, expression and receptor-binding properties of novel vascular endothelial growth factors.

U Eriksson1, K Alitalo.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 9893345     DOI： 10.1007/978-3-642-59953-8_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  30 in total

1.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

Authors:  Christiana Ruhrberg; Holger Gerhardt; Matthew Golding; Rose Watson; Sofia Ioannidou; Hajime Fujisawa; Christer Betsholtz; David T Shima
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

Review 2.  The impact of anti-angiogenic agents on cancer therapy.

Authors:  Dieter Marmé
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-16       Impact factor: 4.553

3.  Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.

Authors:  M Zheng; S Deshpande; S Lee; N Ferrara; B T Rouse
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice.

Authors:  Shumpei Niida; Takako Kondo; Sachie Hiratsuka; Shin-Ichi Hayashi; Norio Amizuka; Tetsuo Noda; Kyoji Ikeda; Masabumi Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  Cloning and expression of the functional human anti-vascular endothelial growth factor (VEGF) using the pcDNA3.1 vector and the human chronic myelogenous leukemia cell line K562.

Authors:  Masoumeh Hajirezaei; Mojtaba Darbouy; Bahram Kazemi
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

6.  Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Authors:  T Veikkola; L Jussila; T Makinen; T Karpanen; M Jeltsch; T V Petrova; H Kubo; G Thurston; D M McDonald; M G Achen; S A Stacker; K Alitalo
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

7.  VEGF-Trap: a VEGF blocker with potent antitumor effects.

Authors:  Jocelyn Holash; Sam Davis; Nick Papadopoulos; Susan D Croll; Lillian Ho; Michelle Russell; Patricia Boland; Ray Leidich; Donna Hylton; Elena Burova; Ella Ioffe; Tammy Huang; Czeslaw Radziejewski; Kevin Bailey; James P Fandl; Tom Daly; Stanley J Wiegand; George D Yancopoulos; John S Rudge
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.

Authors:  Juan Wen; Yuan Zhao; Jinghe Li; Chunyan Weng; Jingjing Cai; Kan Yang; Hong Yuan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2013-02-19       Impact factor: 4.104

9.  Expression of vascular endothelial growth factors A and C in human pancreatic cancer.

Authors:  Rui-Feng Tang; Shu-Xia Wang; Li Peng; Shun-Xiang Wang; Meng Zhang; Zhi-Feng Li; Zhi-Ming Zhang; Yan Xiao; Feng-Rui Zhang
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

10.  Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.

Authors:  Per Lindblom; Holger Gerhardt; Stefan Liebner; Alexandra Abramsson; Maria Enge; Mats Hellstrom; Gudrun Backstrom; Simon Fredriksson; Ulf Landegren; Henrik C Nystrom; Goran Bergstrom; Elisabetta Dejana; Arne Ostman; Per Lindahl; Christer Betsholtz
Journal:  Genes Dev       Date:  2003-08-01       Impact factor: 11.361
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.